| Cerner Primary Mnemonic: | PROMETHEUS Anser VDZ |
| PDM | 1759072 |
| Informatics - Workgroup | Tox/TDM |
| Synonyms * | ANSERVDZ
Vedolizumab
ENTYVIO Ab |
| Display Name * | PROMETHEUS Anser VDZ |
| Specimen Sources (combined Order Entry and Specimen Navigator) * |
|
| Specimen Types (combined Order Entry and Specimen Navigator) * |
|
| Body Fluids (types sent through AOEs) |
|
| Specimen Navigator Specimen Types |
|
| Specimen Navigator Specimen Sources |
|
| Specimen Navigator Short Name | |
| Ordering info (EPIC SmartText) | Serum concentrations of vedolizumab (VDZ) may vary among equally dosed patients which can ultimately affect patient outcomes. Some patients may develop immunogenicity to VDZ by producing antibodies to vedolizumab (ATV) and the presence of persistent anti-vedolizumab antibody has been observed to substantially reduce serum concentrations of vedolizumab. The quantitative measurement of VDZ and ATV levels in serum provides healthcare providers with valuable information to help them gain a better understanding of the factors that may be affecting a patient’s loss of response.
The PROMETHEUS Anser VDZ test is a next generation and more sensitive quantitative monitoring assay that allows healthcare providers to measure and monitor serum VDZ and ATV levels at any time during therapy. Incorporating therapeutic drug monitoring may clarify what factors are contributing to a patient’s loss of response and help guide treatment decisions by providing information to help determine an appropriate course of action.
|
| IP Orderable (inpatient) | No |
| OP Orderable (outpatient) | Yes |
AOEs *
|
| AP AOEs | |
| Special History | No |
| Build Comments | Do Not Build |
| Filter * | |
| Cerner Site Restrict | Prometheus Bioscience |
Cerner Results
| Result Desc |
Result display |
Result PDM |
| Serum vedolizumab (VDZ) concentration |
VDZC |
1759072B |
| Prometheus Laboratory Footer |
PLI Footer |
1759071D |
| Antibodies to vedolizumab (ATV) concentration |
ATVC |
1759072C |
| PROMETHEUS Anser VDZ |
ANSERVDZ |
1759072A |
|
| PROCEDURE ID |
114212 |
| PDM |
1759072 |
| ORDER DISPLAY NAME |
PROMETHEUS Anser VDZ |
| PROCEDURE NAME |
PROMETHEUS ANSER VDZ |
| PROCEDURE MASTER NUMBER |
LAB10852 |
| SHORT PROCEDURE NAME |
PROMETHEUS ANSER VDZ |
| CATEGORY CODE |
1.0 |
| CATEGORY CODE RECORD NAME |
LAB BLOOD ORDERABLES |
| SYNONYMS |
ANSERVDZ
Vedolizumab
ENTYVIO Ab |
| CLINICALLY ACTIVE |
Yes |
| ORDERABLE |
Yes |
| PERFORMABLE |
Yes |
| FILTER GENOMICS |
|
| REFERENCE LINK URL |
https://labs.northwell.edu/epic/test/114212 |
| ORDERING INSTRUCTIONS |
|
| DEFAULT SPECIMEN TYPE |
Blood |
| SPECIMEN TYPE PICK LIST |
Blood |
| SPECIMEN TYPE LIST |
|
| OP SPECIMEN TYPE LIST |
|
| SPECIMEN SOURCE PICK LIST |
Blood, Venous
Blood, Central Line
Blood, Arterial
Blood, Capillary |
| SPECIMEN SOURCE DEFAULT - MALE |
Blood, Venous |
| SPECIMEN SOURCE DEFAULT - FEMALE |
Blood, Venous |
| SPECIMEN SOURCE LIST |
|
| OP SPECIMEN SOURCE LIST |
|
| IP LAB TEST COMPONENTS FOR REPORT |
ATVCONC
PROMANVDZ
PROMLABFT
VEDOLIZUMCN |
| OP LAB TEST COMPONENTS FOR REPORT |
ATVCONC
PROMANVDZ
PROMLABFT
VEDOLIZUMCN |
| ORDER QUESTIONS |
[] |
| ORDER QUESTIONS RECORD NAME |
|
| INPATIENT ORDER QUESTIONS |
[] |
| INPATIENT ORDER QUESTIONS RECORD NAME |
|
| ORDER SPECIFIC QUESTION OVERRIDE |
|
| INPATIENT QUESTION OVERRIDE |
|
| LOCATION RESTRICT LIST IP |
|
| LOCATION RESTRICT LIST IP RECORD NAME |
|
| LOCATION RESTRICT LIST INCLUDE IP |
|
| LOCATION RESTRICT LIST OP |
|
| LOCATION RESTRICT LIST OP RECORD NAME |
|
| LOCATION RESTRICT LIST INCLUDES OP |
|
| EDP AMB ORDER SPECIFIC QUESTIONS RECORD NAME |
|
| EDP IP ORDER SPECIFIC QUESTIONS RECORD NAME |
|
| EDP IP SPECIMEN SOURCE |
Blood, Venous
Blood, Central Line
Blood, Arterial
Blood, Capillary
Blood, Peripheral |
| EDP OP SPECIMEN SOURCE |
|
| EDP IP SPECIMEN TYPE |
Blood |
| EDP OP SPECIMEN TYPE |
|
| DERIVED EDP IP BUTTONS S |
Blood, Capillary
Blood, Arterial
Blood, Central Line
Blood, Venous |
| DERIVED EDP IP BUTTONS T |
Blood |
| DERIVED EDP OP BUTTONS S |
|
| DERIVED EDP OP BUTTONS T |
|
| IP ORDERABLE |
0 |
| OP ORDERABLE |
1 |
| STANDARD LAB COMPONENTS |
|
| STANDARD LAB COMPONENTS RECORD NAME |
|
| COMPONENT DATA REQUIREMENT |
|
EPIC OP AOEs
|
EPIC IP AOEs
|
EPIC Components (results - crosswalked through Cerner)
| Component ID | Component Name | Base Name | Common Name | External Name | Cerner Result PDM |
|---|
| 3047804712.0 |
SERUM VEDOLIZUMAB (VDZ) CONCENTRATION |
VEDOLIZUMCN |
SERUM VEDOLIZUMAB VDZ CONCENTRATION |
Serum vedolizumab (VDZ) concentration |
1759072B |
| 3047804278.0 |
PROMETHEUS LABORATORY FOOTER |
PROMLABFT |
PROMETHEUS LABORATORY FOOTER |
Prometheus Laboratory Footer |
1759071D |
| 3047801081.0 |
ANTIBODIES TO VEDOLIZUMAB (ATV) CONCENTRATION |
ATVCONC |
ANTIBODIES TO VEDOLIZUMAB CONCENTRATION |
Antibodies to vedolizumab concentration |
1759072C |
| 3047804277.0 |
PROMETHEUS ANSER VDZ |
PROMANVDZ |
PROMETHEUS ANSER VDZ |
Prometheus Anser VDZ |
1759072A |
|
